Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Osteosarcoma × Everolimus × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 49 Carcinoma, Renal Cell 44 Neoplasm Metastasis 21 Neoplasms 17 Kidney Neoplasms 16 Neuroendocrine Tumors 14 Lymphoma, Mantle-Cell 12 Carcinoma, Non-Small-Cell Lung 11 Recurrence 10 Prostatic Neoplasms 10 Hodgkin Disease 10 Tuberous Sclerosis 9 Stomach Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma 9 Glioblastoma 9 Colorectal Neoplasms 9 Brain Neoplasms 9 Lymphoma, Follicular 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Carcinoma 8 Waldenstrom Macroglobulinemia 7 Triple Negative Breast Neoplasms 7 Sarcoma 7 Multiple Myeloma 7 Lymphoma, B-Cell, Marginal Zone 7 Glioma 7 Central Nervous System Neoplasms 7 Carcinoma, Neuroendocrine 7

Interventions

Methotrexate 16 Ifosfamide 16 Doxorubicin 13 Filgrastim 11 Etoposide 11 Cisplatin 11 Cyclophosphamide 9 Leucovorin 7 Gemcitabine 7 Sirolimus 6 Irinotecan 5 Granulocyte Colony-Stimulating Factor 5 Carboplatin 5 Topotecan 4 Temozolomide 4 Sorafenib 4 Radiotherapy 4 Docetaxel 4 trimetrexate glucuronate 3 temsirolimus 3 dinutuximab 3 cixutumumab 3 Vincristine 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Imatinib Mesylate 3 tanespimycin 2 sargramostim 2 pegfilgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01804374 2015-06-17

SERIO

Italian Sarcoma Group

Phase 2 Completed

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡